Skip to main content

Advertisement

Log in

CD40LG Triplication Associates with Immune Dysregulation and Exhaustion

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data Availability

Data obtained during the study are available from the corresponding author on reasonable request.

References

  1. Karnell JL, Rieder SA, Ettinger R, Kolbeck R. Targeting the CD40-CD40L pathway in autoimmune diseases: humoral immunity and beyond. Adv Drug Deliv Rev. 2019;141:92–103.

    Article  CAS  Google Scholar 

  2. Yazdani R, Fekrvand S, Shahkarami S, Azizi G, Moazzami B, Abolhassani H, et al. The hyper IgM syndromes: epidemiology, pathogenesis, clinical manifestations, diagnosis and management. Clin Immunol. 2019;198:19–30.

    Article  CAS  Google Scholar 

  3. Mehling A, Loser K, Varga G, Metze D, Luger TA, Schwarz T et al (2001) Overexpression of Cd40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med 615–28. https://doi.org/10.1084/jem.194.5.615

  4. Sun D, Le Coz C, Bunin N, Romberg N (2021) Hematopoietic stem cell transplantation successfully treats CD40LG duplication. J Clin Immunol 1668–70. https://doi.org/10.1007/s10875-021-01085-5

  5. Le Coz C, Trofa M, Syrett CM, Martin A, Jyonouchi H, Jyonouchi S, et al. CD40LG duplication-associated autoimmune disease is silenced by nonrandom X-chromosome inactivation. J Allergy Clin Immunol. 2018;141:2308-11.e7.

    Article  Google Scholar 

Download references

Acknowledgements

Consortium information

Consortium “CD40L consortium” members: Pirjo Åström1, Outi Kuismin2

1Research Unit of Biomedicine, University of Oulu, Oulu, Finland

2Department of Clinical Genetics, PEDEGO Research Unit, Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland

Funding

This study was supported by Oulu University Hospital VTR.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

WS, NP, VG, PÅ: laboratory analysis, writing

OK: Genetic analysis, writing

TH: patient care, study design, writing

Corresponding author

Correspondence to Timo Hautala.

Ethics declarations

Ethics Approval

This study has been completed according to principles of the Helsinki Declaration. The study has been approved by Oulu University Hospital Ethics committee.

Consent to Participate

Informed consent to participate was obtained from the patient.

Consent to Publish

Informed consent to publish was obtained from the patient.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 545 kb).

Supplementary file2 (DOCX 18.5 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Santaniemi, W., Pernaa, N., Glumoff, V. et al. CD40LG Triplication Associates with Immune Dysregulation and Exhaustion. J Clin Immunol 43, 323–326 (2023). https://doi.org/10.1007/s10875-022-01392-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-022-01392-5

Navigation